Role of depression in heart failure--choosing the right antidepressive treatment.

Role of depression in heart failure--choosing the right antidepressive treatment.

Major depression is a common feature of heart failure patients and possibly stems from their common biochemical background. Depression and heart failure co-morbidity has several clinical implications on the prognosis of these patients. Furthermore antidepressive drugs have known cardiovascular side...

Bibliografske podrobnosti
Main Authors:	Tousoulis, D, Antonopoulos, A, Antoniades, C, Saldari, C, Stefanadi, E, Siasos, G, Stougianos, P, Plastiras, A, Korompelis, P, Stefanadis, C
Format:	Journal article
Jezik:	English
Izdano:	2010

Podobne knjige/članki

Circulating biomarkers for the diagnosis and prognosis of heart failure.
od: Tousoulis, D, et al.
Izdano: (2009)

Antidepressive treatment as a modulator of inflammatory process in patients with heart failure: effects on proinflammatory cytokines and acute phase protein levels.
od: Tousoulis, D, et al.
Izdano: (2009)

L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis?
od: Siasos, G, et al.
Izdano: (2007)

Rosuvastatin but not ezetimibe improves endothelial function in patients with heart failure, by mechanisms independent of lipid lowering.
od: Gounari, P, et al.
Izdano: (2010)

Matrix metallopropteinases in heart failure.
od: Tousoulis, D, et al.
Izdano: (2012)

Heart regeneration: what cells to use and how?
od: Tousoulis, D, et al.
Izdano: (2008)

Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective.
od: Tousoulis, D, et al.
Izdano: (2007)

Relationship between the pharmacokinetics of levosimendan and its effects on cardiovascular system.
od: Antoniades, C, et al.
Izdano: (2009)

Selective serotonin reuptake inhibitors modify the effect of beta-blockers on long-term survival of patients with end-stage heart failure and major depression.
od: Tousoulis, D, et al.
Izdano: (2008)

New biochemical markers in acute coronary syndromes.
od: Tousoulis, D, et al.
Izdano: (2008)

The failure of immunomodulation therapy in heart failure: does the statins "paradigm" prove the rule?
od: Tousoulis, D, et al.
Izdano: (2010)

Levosimendan: a novel agent in heart failure.
od: Koumallos, N, et al.
Izdano: (2006)

Adiponectin as a Biomarker at Different Stages of Ischaemic Heart Disease: From Obesity to Ischaemic Heart Failure
od: Antonopoulos, A, et al.
Izdano: (2009)

Effects of irbesartan and perindopril on forearm reactive hyperemia and inflammatory process, in normotensive patients with coronary artery disease.
od: Tousoulis, D, et al.
Izdano: (2008)

Levosimendan: beyond its simple inotropic effect in heart failure.
od: Antoniades, C, et al.
Izdano: (2007)

The role of adiponectin at different stages of atherosclerosis in heart failure: associations with myocardial redox state
od: Antonopoulos, A, et al.
Izdano: (2010)

Potential role of endothelial progenitor cells in the pathophysiology of heart failure: clinical implications and perspectives.
od: Andreou, I, et al.
Izdano: (2006)

Cold pressor test as a marker for the detection of early stage coronary atherosclerosis.
od: Tousoulis, D, et al.
Izdano: (2007)

Adiponectin: from obesity to cardiovascular disease.
od: Antoniades, C, et al.
Izdano: (2009)

Adiponectin: From obesity to cardiovascular disease: Etiology and Pathophysiology
od: Antoniades, C, et al.
Izdano: (2009)

Biomarkers of premature atherosclerosis.
od: Kampoli, A, et al.
Izdano: (2009)

Short-term treatment with L-arginine prevents the smoking-induced impairment of endothelial function and vascular elastic properties in young individuals.
od: Siasos, G, et al.
Izdano: (2008)

The impact of oral L-arginine supplementation on acute smoking-induced endothelial injury and arterial performance.
od: Siasos, G, et al.
Izdano: (2009)

Inflammatory and thrombotic processes are associated with vascular dysfunction in children with familial hypercholesterolemia.
od: Charakida, M, et al.
Izdano: (2009)

Oxidative stress and inflammatory process in patients with atrial fibrillation: the role of left atrium distension.
od: Tousoulis, D, et al.
Izdano: (2009)

Genetic polymorphisms of platelet glycoprotein Ia and the risk for premature myocardial infarction: effects on the release of sCD40L during the acute phase of premature myocardial infarction.
od: Antoniades, C, et al.
Izdano: (2006)

Methionine-loading rapidly impairs endothelial function, by mechanisms independent of endothelin-1: evidence for an association of fasting total homocysteine with plasma endothelin-1 levels.
od: Tousoulis, D, et al.
Izdano: (2008)

The CD40/CD40 ligand system: linking inflammation with atherothrombosis.
od: Antoniades, C, et al.
Izdano: (2009)

Novel therapies targeting vascular endothelium
od: Tousoulis, D, et al.
Izdano: (2011)

Effects of lipid profile on forearm hyperemic response in young subjects.
od: Antoniades, C, et al.
Izdano: (2006)

Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials.
od: Antoniades, C, et al.
Izdano: (2009)

Genetic polymorphism A1675G of the angiotensin type 2 receptor and its role in hypertension
od: Koumallos, N, et al.
Izdano: (2011)

Common community infections and the risk for coronary artery disease and acute myocardial infarction: evidence for chronic over-expression of tumor necrosis factor alpha and vascular cells adhesion molecule-1.
od: Nikolopoulou, A, et al.
Izdano: (2008)

Interaction between cytokines and sCD40L in patients with stable and unstable coronary syndromes.
od: Tousoulis, D, et al.
Izdano: (2007)

Red wine and vascular endothelium
od: Tousoulis, D, et al.
Izdano: (2009)

Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure.
od: Tousoulis, D, et al.
Izdano: (2005)

Effects of insulin dependence on inflammatory process, thrombotic mechanisms and endothelial function, in patients with type 2 diabetes mellitus and coronary atherosclerosis.
od: Antoniades, C, et al.
Izdano: (2007)

Do endothelial progenitor cells modify our strategy to treat risk factors?
od: Tousoulis, D, et al.
Izdano: (2010)

Do endothelial progenitor cells modify our strategy to treat risk factors?
od: Tousoulis, D, et al.
Izdano: (2011)

Effects of atorvastatin on reactive hyperaemia and the thrombosis-fibrinolysis system in patients with heart failure.
od: Tousoulis, D, et al.
Izdano: (2005)